Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barré syndrome
<p>Abstract</p> <p>Background</p> <p>Controlled trials have found therapeutic plasma exchange (TPE) and intravenous immunoglobulin (IVIg) infusion therapy to be equally efficacious in treating Guillain-Barré syndrome (GBS). Due to increases in the price of IVIg compare...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2011-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!